Global Celiac Disease Treatment Market Insights Forecasts to 2033

• The Global Celiac Disease Treatment Market Size was Valued at USD 0.62 Billion in 2023
• The Market Size is Growing at a CAGR of 9.45% from 2023 to 2033
• The Worldwide Celiac disease treatment Market Size is Expected to Reach USD 1.53 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Celiac Disease Treatment Market Size is Anticipated to Exceed USD 1.53 Billion by 2033, Growing at a CAGR of 9.45% from 2023 to 2033.

Market Overview

Celiac disease (CD) is a chronic digestive disorder characterized by inflammation or irritation of the small intestine, making it difficult to absorb nutrients from the diet. Patients often have other family members with the condition, causing susceptibility to the condition. Inflammation of the bowels occurs when the individual begins to eat food that contains gluten. CD is usually diagnosed in adulthood, and the condition is more common in women than in men. Gluten is a specific protein found in wheat, barley, rye, and related grains. Oats are not recommended for individuals suffering from CD, due to their high potential for contamination with other gluten-containing grains. When gluten-containing food reaches the small intestine, the immune system reacts against the gluten, triggering an inflammatory response in the intestinal walls This inflammation temporarily damages the villi, reducing the absorption of food. When gluten is removed from the diet, inflammation decreases and the intestine begins to heal.

Report Coverage

This research report categorizes the market for the global celiac disease treatment market based on various segments and regions forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global celiac disease treatment market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global celiac disease treatment market.

Driving Factors

Celiac disease therapy relies on adhering to a strict gluten-free diet, which can improve symptoms like diarrhea, bloating, lethargy, and malnutrition. Long-term commitment to this diet can prevent osteoporosis, infertility, and certain gastrointestinal cancers. Early detection and treatment reduce the risk of severe intestine damage and improve nutritional absorption, leading to increased energy and better overall health. Furthermore, the celiac disease treatment market is growing due to global prevalence, increased awareness, and the usage of advanced diagnostic methods. Consumer demand for gluten-free products and new therapies such as enzyme therapies and immune-modulating drugs are driving innovation. Health organizations and government initiatives are creating awareness of early detection and diagnosis. The rise in related conditions such as osteoporosis and infertility is also increasing the demand for effective treatments. 

Restraining Factors

Celiac disease treatment faces challenges due to the lack of comprehensive treatment and the prevalence of gluten in everyday foods. The high cost and lack of availability of gluten-free products in some areas further hamper treatment compliance. Cross-contamination in food situations makes surveillance difficult, and misdiagnosis or delayed diagnosis is due to widespread symptoms. Psychological stress and social isolation hinder long-term adherence to the diet, making it psychologically taxing for patients.

Market Segmentation

The global celiac disease treatment market share is classified into diagnosis, treatment, and end-use.

• The serological tests segment is expected to hold the largest share of the global celiac disease treatment market during the forecast period.   

Based on the diagnosis, the global celiac disease treatment market is divided into serological tests, genetic testing, and biopsy. Among these, the serological tests segment is expected to hold the largest share of the global celiac disease treatment market during the forecast period. Serological tests, which are non-invasive and easy to use, are experiencing significant growth in the celiac disease treatment market due to their ability to detect the disease with high accuracy. Increasing awareness of celiac disease, advances in diagnostic technology, and the demand for rapid and accurate diagnosis are driving the growth of this segment.

• The gluten-free diets segment is expected to grow at the fastest CAGR in the global celiac disease treatment market during the forecast period.   

Based on the treatment, the global celiac disease treatment market is divided into vitamin and mineral supplements, gluten-free diets, and medical therapies. Among these, the gluten-free diets segment is expected to grow at the fastest CAGR in the global celiac disease treatment market during the forecast period. Growth of the gluten-free foods segment is expected to increase due to increasing concerns about gluten intolerance, advances in gluten-free foods, and healthy food options but demand for medical treatment mainly due to research and continuous development aimed at providing novel therapeutics treatment.

• The hospitals & clinics segment is expected to grow at the fastest CAGR in the global celiac disease treatment market during the forecast period.   

Based on the end-use, the global celiac disease treatment market is divided into research centers, hospitals & clinics, and others. Among these, the hospital & clinics segment is expected to grow at the fastest CAGR in the global celiac disease treatment market during the forecast period. The hospitals & clinics segment will grow exponentially with the increasing prevalence of celiac disease, resulting in more patients seeking formal diagnosis and treatment in hospitals. Improvements in diagnostic and therapeutic techniques are expected to increase patient visits, making this segment important in the management of the disease.

Regional Segment Analysis of the Global Celiac Disease Treatment Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global celiac disease treatment market over the predicted timeframe.

North America is anticipated to hold the largest share of the global celiac disease treatment market over the predicted timeframe. The region is expected to dominate the global celiac disease treatment market due to its high prevalence, increased awareness, and well-established healthcare infrastructure. The presence of large pharmaceutical companies in the U.S. and ongoing research into new treatments for celiac disease. and the widespread availability of gluten-free products contributes to the market dominance in this region.

Asia Pacific is expected to grow at the fastest pace in the global celiac disease treatment market during the forecast period. This growth is due to increased awareness of celiac disease, rising healthcare infrastructure, and improved diagnostic capabilities in these countries. Furthermore, increasing trends in gluten intolerance and dietary changes along with the wide availability of gluten-free products are contributing to the rapid expansion of this segment’s market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global celiac disease treatment market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• ImmusanT 
• Takeda Pharmaceutical Company 
• Innovate Biopharmaceuticals 
• Glutenostics 
• BioLineRx 
• Calypso Biotech 
• Amgen 
• F. Hoffmann-La Roche Ltd 
• Pfizer Inc. 
• ImmunogenX 
• Anokion 
• Nestlé Health Science 
• Johnson & Johnson 
• Sanofi 
• Merck & Co., Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In April 2023, Innate Pharma signed an exclusive licensing agreement with Takeda, which gives Takeda worldwide rights to study and develop antibody-drug conjugates against an anonymous target, notably Celiac disease.

• In October 2022, Takeda, Zedira, and Dr. Falk Pharma GmbH signed a collaboration and licensing agreement to develop ZED1227/TAK-227, a Phase 2b investigational therapy for celiac disease treatment.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global celiac disease treatment market based on the below-mentioned segments: 

Global Celiac Disease Treatment Market, By Diagnosis

• Serological Tests
• Genetic Testing
• Biopsy

Global Celiac Disease Treatment Market, By Treatment

• Vitamin and Mineral Supplements
• Gluten-Free Diets
• Medical Therapies

Global Celiac Disease Treatment Market, By End-Use

• Research Centers
• Hospitals & Clinics
• Others

Global Celiac Disease Treatment Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa